Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Neurology and Neuroscience Reports
Published in: Current Neurology and Neuroscience Reports 10/2014

01-10-2014 | Neurology of Systemic Disease (J Biller, Section Editor)

Neurologic Manifestations of Gastrointestinal and Liver Diseases

Authors: José M. Ferro, Sofia Oliveira

Published in: Current Neurology and Neuroscience Reports | Issue 10/2014

Login to get access

Abstract

Hepatic and gastrointestinal disorders can produce a wide spectrum of neurologic complications both affecting the central nervous system (CNS) and the peripheral nervous system. These manifestations range in severity from coma in acute liver failure and acute pancreatitis, to minor cognitive changes in chronic portosystemic encephalopathy and hepatitis C. Cerebrovascular diseases can complicate hepatitis C infection and inflammatory bowel disease. Demyelinating disorders may co-exist with inflammatory bowel disease. Anti-tumor necrosis factor alpha drugs may induce demyelination. Ataxia may occur in malabsorption syndromes and in gluten related disorders. Characteristic movement disorders are key features of acquired hepatocerebral degeneration and of Whipple disease. Multiple types of neuropathy can be found in association with hepatitis, inflammatory bowel disease and gluten related disorders.
Literature
1.
2.
Datar S, Wijdicks EF. Neurologic manifestations of acute liver failure. Handb Clin Neurol. 2014;120:645–59.PubMedCrossRef
3.•
Scott TR, Kronsten VT, Hughes RD, Shawcross DL. Pathophysiology of cerebral oedema in acute liver failure. World J Gastroenterol. 2013;19:9240–55. A comprehensive basic science review of the pathophysiology of liver failure and hepatic encephalopathy.PubMedCrossRefPubMedCentral
4.
5.
Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol. 2010;7:515–25.PubMedCrossRef
6.
7.•
Nardone R, Höller Y, Storti M, et al. Spinal cord involvement in patients with cirrhosis. World J Gastroenterol. 2014;20:2578–85. A clinically oriented review of this rare complication of chronic hepatic failure.PubMedCrossRefPubMedCentral
8.
9.
10.
Fernández-Rodriguez R, Contreras A, De Villoria JG, Grandas F. Acquired hepatocerebral degeneration: clinical characteristics and MRI findings. Eur J Neurol. 2010;17:1463–70.PubMedCrossRef
11.
Maffeo E, Montuschi A, Stura G, Giordana MT. Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients. Neurol Sci. 2014;35:523–30.PubMedCrossRef
12.
Junker AE, Als-Nielsen B, Gluud C, Gluud LL. Dopamine agents for hepatic encephalopathy. Cochrane Database Syst Rev. 2014;2, CD003047.PubMed
13.•
Stracciari A, Baldin E, Cretella L, et al. Chronic acquired hepatocerebral degeneration: effects of liver transplantation on neurological manifestations. Neurol Sci. 2011;32:411–5. A case series of 3 patients with acquired hepatocerebral degeneration who received hepatic transplant showing improvement in 2 of them.PubMedCrossRef
14.
El Moutawakil B, Bourezgui M, Rafai MA, et al. Acute disseminated encephalomyelitis associated with hepatitis A virus infection. Rev Neurol (Paris). 2008;164:852–4.CrossRef
15.
Yimam KK, Merriman RB, Todd FR. A rare case of acute hepatitis B virus infection causing Guillain-Barre syndrome. Gastroenterol Hepatol (NY). 2013;9:121–3.
16.
Mehndiratta M, Pandey S, Nayak R, Saran RK. Acute onset distal symmetrical vasculitic polyneuropathy associated with acute hepatitis B. J Clin Neurosci. 2013;20:331–2.PubMedCrossRef
17.•
Monaco S, Ferrari S, Gajofatto A, et al. HCV-related nervous system disorders. Clin Dev Immunol. 2012;2012:236148. An extensive review of the mechanisms and clinical aspects of HCV neurologic complications.PubMedCrossRefPubMedCentral
18.
Adinolfi LE, Zampino R, Restivo L, et al. Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms. World J Gastroenterol. 2014;20:3410–7.PubMedCrossRefPubMedCentral
19.
Huang H, Kang R, Xhao Z. Hepatitis C vírus infection and risk of stroke: a systematic review and meta-analysis. PloS One. 2013;8(11):e81305.CrossRef
20.
Ahmad D, Ilias Basha H, Towfiq B, Bachuwa G. Resolution of neurological deficits secondary to spontaneous intracranial haemorrhage and posterior reversible encephalopathy syndrome (PRES) in a patient with hepatitis C-associated cryoglobulinaemia: a role for plasmapheresis. BMJ Case Rep. 2014;2014.
21.•
Cheung MC, Maguire J, Carey I, et al. Review of the neurological manifestations of hepatitis E infection. Ann Hepatol. 2012;11:618–22. A literature review of 25 cases of patients with hepatitis E and neurologic manifestations.PubMed
22.•
Hornik A, Rodriguez Porcel FJ, Agha C, et al. Central and extrapontine myelinolysis affecting the brain and spinal cord. An unusual presentation of pancreatic encephalopathy. Front Neurol. 2012;3:135. Case report of a woman with pancreatitis, encephalopathy and pontine and extrapontine myelinolysis.PubMedPubMedCentral
23.
Estrada RV, Moreno J, Martinez E, et al. Pancreatic encephalopathy. Acta Neurol Scand. 1979;59:135–9.PubMedCrossRef
24.
Arana-Guajardo AC, Cámara-Lemarroy CR, Rendón-Ramírez EJ, et al. Wernicke encephalopathy presenting in a patient with severe acute pancreatitis. JOP. 2012;13:104–7.PubMed
25.
Ahrens CL, Manno EM. Neurotoxicity of commonly used hepatic drugs. Handb Clin Neurol. 2014;120:675–82.PubMedCrossRef
26.
Ferro JM, Oliveira SN, Correia L. Neurologic manifestations of inflammatory bowel diseases. Handb Clin Neurol. 2014;120:595–605.PubMedCrossRef
27.
Oliveira GR, Teles BC, Brasil EF, et al. Peripheral neuropathy and neurological disorders in an unselected Brazilian population-based cohort of IBD patients. Inflamm Bowel Dis. 2008;14:389–95.PubMedCrossRef
28.
Gondim FA, Brannagan TH, Sander HW, et al. Peripheral neuropathy in patients with inflammatory bowel disease. Brain. 2005;128:867–79.PubMedCrossRef
29.
Canero A, Parmeggiani D, Avenia N, et al. Thromboembolic tendency (TE) in IBD (Inflammatory bowel disease) patients. Ann Ital Chir. 2012;83:313–7.PubMed
30.
Kappelman MD, Horvath-Puho E, Sandler RS, et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut. 2011;60:937–43.PubMedCrossRef
31.
Barclay AR, Keightley JM, Horrocks I, et al. Cerebral thromboembolic events in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:677–83.PubMedCrossRef
32.
Benavente L, Morís G. Neurologic disorders associated with inflammatory bowel disease. Eur J Neurol. 2011;18:138–43.PubMedCrossRef
33.•
Cognat E, Crassard I, Denier C, et al. Cerebral venous thrombosis in inflammatory bowel diseases: eight cases and literature review. Int J Stroke. 2011;6:487–92. A case series of 8 patients cerebral venous thrombosis associated with inflammatory bowel diseases followed by a literature review.PubMedCrossRef
34.
Bermejo PE, Burgos A. Neurological complications of inflammatory bowel disease. Med Clin (Barc). 2008;130:666–75.CrossRef
35.
Kreuzpaintner G, Horstkotte D, Heyll A, et al. Increased risk of bacterial endocarditis in inflammatory bowel disease. Am J Med. 1992;92:391–5.PubMedCrossRef
36.
Chentanez T, Khawcharoenporn T, Chokrungvaranon N, et al. Cardiobacterium hominis endocarditis presenting as acute embolic stroke: a case report and review of the literature. Heart Lung. 2011;40:262–9.PubMedCrossRef
37.
Gobron C, Kaci R, Sokol H, et al. Unilateral carotid granulomatous arteritis and Crohn's disease. Rev Neurol (Paris). 2010;166:542–6.CrossRef
38.
Nudelman RJ, Rosen DG, Rouah E, Verstovsek G. Cerebral sinus thrombosis: a fatal neurological complication of ulcerative colitis. Pathol Res Int. 2010;2010:132754.CrossRef
39.
Casella G, Spreafico C, Costantini M, et al. Cerebral sinus thrombosis in ulcerative colitis. Inflamm Bowel Dis. 2011;17:2214–6.PubMedCrossRef
40.
Katsanos AH, Katsanos KH, Kosmidou M, et al. Cerebral sinus venous thrombosis in inflammatory bowel diseases. QJM. 2012;106:401–13.PubMedCrossRef
41.
Tsujikawa T, Urabe M, Bamba H, et al. Haemorrhagic cerebral sinus thrombosis associated with ulcerative colitis: a case report of successful treatment by anticoagulant therapy. J Gastroenterol Hepatol. 2000;15:688–92.PubMedCrossRef
42.
Philips MF, Bagley LJ, Sinson GP, et al. Endovascular thrombolysis for symptomatic cerebral venous thrombosis. J Neurosurg. 1999;90:65–71.PubMedCrossRef
43.
Kothur K, Kaul S, Rammurthi S, et al. Use of thrombolytic therapy in cerebral venous sinus thrombosis with ulcerative colitis. Ann Indian Acad Neurol. 2012;15:35–8.PubMedCrossRefPubMedCentral
44.
Rang EH, Brooke BN, Hermon-Taylor J. Association of ulcerative colitis with multiple sclerosis. Lancet. 1982;2:555.PubMedCrossRef
45.
Pandian JD, Pawar G, Singh GS, et al. Multiple sclerosis in a patient with chronic ulcerative colitis. Neurol India. 2004;52:282–3.PubMed
46.
Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology. 2005;129:827–36.PubMedCrossRef
47.
Gupta G, Gelfand JM, Lewis JD. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology. 2005;129:819–26.PubMedCrossRef
48.
Thomas Jr CW, Weinshenker BG, Sandborn WJ. Demyelination during anti-tumor necrosis factor therapy with infliximab for Crohn’s disease. Inflamm Bowel Dis. 2004;10:28–31.PubMedCrossRef
49.
Freeman HJ, Flak B. Demyelination-like syndrome in Crohn’s disease after infliximab therapy. Can J Gastroenterol. 2005;19:313–6.PubMed
50.
Sacher M, Göpfrich H, Hochberger O. Crohn's disease penetrating into the spinal canal. Acta Paediatr Scand. 1989;78:647–9.PubMedCrossRef
51.
Hershkowitz S, Link R, Ravden M, Lipow K. Spinal empyema in Crohn's disease. J Clin Gastroenterol. 1990;12:67–9.PubMedCrossRef
52.
Heidemann J, Spinelli KS, Otterson MF, Binion DG. Case report: magnetic resonance imaging in the diagnosis of epidural abscess complicating perirectal fistulizing Crohn's disease. Inflamm Bowel Dis. 2003;9:122–4.PubMedCrossRef
53.
Laplante P, Vanase M, Michaud J, et al. A progressive neurological syndrome associated with an isolated vitamin E deficiency. Can J Neurol Sci. 1984;11(4 Suppl):561–4.PubMed
54.
Ayuso Blanco T, Martin Martinez J, Figueras P, et al. Chronic polyneuropathy due to vitamin E deficiency. Neurologia. 1994;9:300–2.PubMed
55.
Rino Y, Suzuki Y, Kuroiwa Y, et al. Vitamin E malabsorption and neurological consequences after gastrectomy for gastric cancer. Hepato–Gastroenterol. 2007;54:1858–61.
56.
Ueda N, Suzuki Y, Rino Y, et al. Correlation between neurological dysfunction with vitamin E deficiency and gastrectomy. J Neurol Sci. 2009;287:216–20.PubMedCrossRef
57.
Sokol RJ, Kim YS, Hoofnagle JH, et al. Intestinal malabsorption of vitamin E in primary biliary cirrhosis. Gastroenterology. 1989;96:479–86.PubMed
58.
Yokota T, Tsuchiya K, Furukawa T, et al. Vitamin E deficiency in acquired fat malabsorption. J Neurol. 1990;237:103–6.PubMedCrossRef
59.
Aslam A, Misbah SA, Talbot K, et al. Vitamin E deficiency induced neurological disease in common variable immunodeficiency: two cases and review of literature of vitamin E deficiency. Clin Immunol. 2004;112:24–9.PubMedCrossRef
60.
Howard L, Ovesen L, Satya-Murti S, et al. Reversible neurological symptoms caused by vitamin E deficiency in a patient with short bowel syndrome. Am J Clin Nutr. 1982;36:1243–9.PubMed
61.
Vorgerd M, Tegenthoff M, Kühne D, et al. Spinal MRI in progressive myeloneuropathy associated with vitamin E deficiency. Neuroradiology. 1996;38 Suppl 1:S111–3.PubMedCrossRef
62.
63.
Wernicke C. Lehrbuch der Gehirnkrankheiten fur Aerzte und Studirende. Kassel: Theodor Fisher; 1881.
64.
Rothrock JF, Smith MS. Wernicke’s disease complicating surgical therapy for morbid obesity. J Clin Neuroophthalmol. 1981;1:195–9.PubMed
65.
Aasheim ET, Bjorkman S, Sevik TT, et al. Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr. 2009;90:15–22.PubMedCrossRef
66.
Aasheim ET. Wernicke encephalopathy after bariatric surgery: a systematic review. Ann Surg. 2008;248:714–20.PubMed
67.
Kramer LD, Locke GE. Wernicke’s encephalopathy. Complication of gastric plication. J Clin Gastroenterol. 1987;9:549–52.PubMedCrossRef
68.
69.
Berger JR, Singhal D. The neurologic complications of bariatric surgery. Handb Clin Neurol. 2014;120:587–94.PubMedCrossRef
70.
Anderes E, Nand S. Commonly used drugs in hematologic disorders. Handb Clin Neurol. 2014;120:1125–39.PubMedCrossRef
71.
72.
Kumar N, Gross Jr JB, Ahlskog JE. Copper deficiency myelopathy produces a clinical picture like subacute degeneration. Neurology. 2004;63:33–9.PubMedCrossRef
73.
Kumar N, Ahlskog JE, Klein CJ, et al. Imaging features of copper deficiency myelopathy: a study of 25 cases. Neuroradiology. 2006;48:78–83.PubMedCrossRef
74.
Abarbanel JM, Berginer VM, Osimani A, et al. Neurologic complications after gastric restriction surgery for morbid obesity. Neurology. 1987;37:196–200.PubMedCrossRef
75.
Peters G, du Plessis DG, Humphrey PR. Cerebral Whipple’s disease with a stroke-like presentation and cerebrovascular pathology. J Neurol Neurosurg Psychiatry. 2002;73:336–9.PubMedCrossRefPubMedCentral
76.
Lagier J-C, Fenollar F, Lepidi H, et al. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple’s disease. J Antimicrob Chemother. 2010;65:2005–12.PubMedCrossRef
77.
Cirignotta F, Manconi M, Mondini S, et al. Wernicke-Korsakoff encephalopathy and polyneuropathy after gastroplasty for morbid obesity: report of a case. Arch Neurol. 2000;57:1356–9.PubMedCrossRef
78.
Compain C, Sacre K, Puéchal X, et al. Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up. Medicine. 2013;92:324–30.PubMedCrossRef
79.•
Mohamed W, Neil E, Kupsky WJ, et al. Isolated intracranial Whipple's disease—report of a rare case and review of the literature. J Neurol Sci. 2011;308:1–8. A case report and systematic review of 24 cases of isolated intracranial presentation of Whipple’s disease. Most cases had a rapidly progressive atypical dementia.PubMedCrossRef
80.
Blanc F, Ben Abdelghani K, Schramm F, et al. Whipple limbic encephalitis. Arch Neurol. 2011;68:1471–3.PubMedCrossRef
81.
Black DF, Aksamit AJ, Morris JM. MR imaging of central nervous system Whipple disease: a 15-year review. AJNR. 2010;31:1493–7.PubMedCrossRef
82.
Hadjivassiliou M, Duker AP, Sanders DS. Gluten-related neurologic dysfunction. Handb Clin Neurol. 2014;120:607–19.PubMedCrossRef
83.
Briani C, Zara G, Alaedini A, et al. Neurological complications of coeliac disease and autoimmune mechanisms: a prospective study. J Neuroimmunol. 2008;195:171–5.PubMedCrossRef
84.
Hadjivassiliou M, Maki M, Sanders DS, et al. Autoantibody targeting of Brain. and intestinal transglutaminase in gluten ataxia. Neurology. 2006;66:373–7.PubMedCrossRef
85.
Hadjivassiliou M, Aeschlimann P, Strigun A, et al. Autoantibodies in gluten ataxia recognise a novel neuronal transglutaminase. Ann Neurol. 2008;64:332–43.PubMedCrossRef
86.
Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, et al. Clinical, radiological, neurophysiological and neuropathological characteristics of gluten ataxia. Lancet. 1998;352:1582–5.PubMedCrossRef
87.
88.
Deconinck N, Scaillon M, Segers V, et al. Opsoclonus-myoclonus associated with celiac disease. Pediatr Neurol. 2006;34:312–4.PubMedCrossRef
89.
90.•
Currie S, Hadjivassiliou M, Clark MJ, et al. Should we be ‘nervous’ about coeliac disease? Brain. abnormalities in patients with coeliac disease referred for neurological opinion. J Neurol Neurosurg Psychiatry. 2012;83:1216–21. A detailed quantified MR study indicating that patients with gluten sensitivity have decreased cerebellar volume and other MR abnormalities.PubMedCrossRef
91.
Hadjivassiliou M, Grünewald RAG, Lawden M, et al. Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology. 2001;56:5–388.
92.
Hu WT, Murray JA, Greenway MC, et al. Cognitive impairment and celiac disease. Arch Neurol. 2006;63:1440–6.PubMedCrossRef
93.
Ludvigsson JF, Zingone F, Tomson T, et al. Increased risk of epilepsy in biopsy-verified celiac disease: a population-based cohort study. Neurology. 2012;78:1401–7.PubMedCrossRef
94.
95.
Luostarinen L, Himanen SL, Luostarinen M, et al. Neuromuscular and sensory disturbances in patients with well treated celiac disease. J Neurol Neurosurg Psychiatry. 2003;74:490–4.PubMedCrossRefPubMedCentral
96.
97.
Hadjivassiliou M, Rao DS, Wharton SB, et al. Sensory ganglionopathy due to gluten sensitivity. Neurology. 2010;75:1003–8.PubMedCrossRef
98.
Henriksson KG, Hallert C, Norrby K, et al. Polymyositis and adult celiac disease. Acta Neurol Scand. 1982;65:301–19.PubMedCrossRef
99.
Hadjivassiliou M, Chattopadhyay AK, Grunewald RA, et al. Myopathy associated with gluten sensitivity. Muscle Nerve. 2007;35:443–50.PubMedCrossRef
Metadata
Title
Neurologic Manifestations of Gastrointestinal and Liver Diseases
Authors
José M. Ferro
Sofia Oliveira
Publication date
01-10-2014
Publisher
Springer US
Published in
Current Neurology and Neuroscience Reports / Issue 10/2014
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-014-0487-z

Other articles of this Issue 10/2014

Current Neurology and Neuroscience Reports 10/2014 Go to the issue

Infection (ML Solbrig, Section Editor)

Endogenous Retrovirus-K and Nervous System Diseases

Demyelinating Disorders (DN Bourdette and V Yadav, Section Editors)

Gut Microbiome and Multiple Sclerosis

Neuroimaging (DJ Brooks, Section Editor)

Disruption of Resting Functional Connectivity in Alzheimer’s Patients and At-Risk Subjects

Neurotrauma (J Levine, Section Editor)

Inflammation and Immune System Activation After Traumatic Brain Injury

Demyelinating Disorders (DN Bourdette and V Yadav, Section Editors)

X-Linked Adrenoleukodystrophy: Pathogenesis and Treatment

Demyelinating Disorders (DN Bourdette and V Yadav, Section Editors)

Remyelination and Multiple Sclerosis: Therapeutic Approaches and Challenges